YouthAIDS
AIDSMark



PSI in Myanmar

PSI/Myanmar was founded in 1995. An early focus on HIV prevention expanded into reproductive health and STI treatment. In 2001, malaria prevention products were added to its portfolio, which has now grown to include pneumonia, diarrhea and malaria treatment, as well as household water treatment. PSI/Myanmar is based in the former capital of Myanmar and the country’s commercial center, Yangon. It has eight smaller project offices located nationwide.


Partners

Local partners include Médecins sans Frontières (Holland), Médecins du Monde, World Vision, CARE and Save the Children, as well as UN agencies. PSI/Myanmar also coordinates with the Myanmar Medical Association and the Ministry of Health.

PSI/Myanmar’s Sun Quality Health (SQH) network is comprised of over 800 particularly valuable partners. Private physicians across Myanmar are trained and monitored by PSI/Myanmar on the provision of reproductive health services and treatment for malaria, TB, pneumonia and sexually transmitted infections.


Current Donors

The Bill & Melinda Gates Foundation, Danida, a large anonymous donor, the United States Agency for International Development, UNFPA, UNICEF, and the Three Diseases Fund.


HIV/AIDS and STIs

PSI/Myanmar operates two voluntary testing and counseling centers and 10 drop-in-centers that provide educational activities and clinical services for female sex workers and men who have sex with men. Management of sexually-transmitted infections is offered through the SQH network and at drop-in center clinics using Cur-U pre-packaged treatment kits. PSI/Myanmar also deploys outreach workers to conduct educational sessions with clients of sex-workers. Since the launch of Aphaw in 1996, annual condom sales have risen from 400,000 to approximately 20 million in 2007.

PSI/Myanmar has also introduced products such as feel for women and feel for men condoms targeted toward Myanmar’s highest-risk groups.


Malaria

PSI/Myanmar’s malaria programming includes behavior change communication to enhance knowledge and appropriate preventative behaviors. SupaTab insecticide treatment tablets are used to treat bednets for malaria prevention and Sure brand rapid diagnostic test kits and malaria treatment are made available by SQH providers. Sure’s artesunate combination therapy will be replaced by the WHO-recommended Coartem, branded as Malarpack, in 2008.


Reproductive Health

In 2007, SQH providers conducted approximately 860,000 reproductive health consultations. PSI/Myanmar makes the following products available via retailers, pharmacists and SQH providers: male and female condoms, daily contraceptive pills, one- and three-month injectable contraception, intrauterine devices and emergency contraception.


Child Survival/Diarrheal Disease

WaterGuard provides a simple, cost-effective means of preventing diarrhea, cholera, typhoid and other waterborne diseases.


Tuberculosis

PSI/Myanmar introduced DOTS into the SQH network in 2004 and continues to scale up services. To date, 415 SQH providers have registered more than 11,500 TB cases and achieved a treatment success rate of approximately 80%.


Pneumonia

As an extension of services provided by SQH doctors, a pneumonia treatment program was launched in early 2008 and offers treatment (Trimox brand products) to children under five.


The Bill & Melinda Gates Foundation and PSI signed a $25 million grant in December 2008 to demonstrate in Myanmar the effectiveness of private sector approaches to deliver integrated health services at scale in low-income environments through the social marketing of commodities and a private physician franchise network for HIV, malaria, tuberculosis, reproductive health and child health like pneumonia and diarrhea.

Health Impact
In 2007, PSI/Myanmar estimates that it averted over 56,000 unwanted pregnancies, more than 28,000 episodes of diarrhea and more than 16,000 cases of malaria.
spacer
PSI programs target 
Myanmar's highest risk populations including children under five from 
low-income families.

PSI programs target
Myanmar's highest risk populations including children under five from
low-income families.

Publications

• Fact Sheet: PSI/Myanmar

PDF 429K
AIDSMark Regional Lessons Learned: Asia

PDF 192K
A Golden Opportunity: Preventing HIV/AIDS in Myanmar

PDF 135K
PSI in the News highlights PSI's worldwide coverage

 

News


Pioneering TB Testing and Treatment

• DFID's quarterly magazine developments features PSI/Myanmar's HIV/AIDS program


Contact Info

 
About | Programs | Where | Help | Experience
Jobs |  Resources | Contact | Home | Sitemap | Privacy